about
The predictive power of brain mRNA mappings for in vivo protein density: a positron emission tomography correlation studyThe methodology of TSPO imaging with positron emission tomographyKinetic modeling without accounting for the vascular component impairs the quantification of [(11)C]PBR28 brain PET dataParametric imaging of ¹⁸F-fluoro-3-deoxy-3-L-fluorothymidine PET data to investigate tumour heterogeneity.Kinetic analysis of hyperpolarized data with minimum a priori knowledge: Hybrid maximum entropy and nonlinear least squares method (MEM/NLS).MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas.A Variational Bayesian inference method for parametric imaging of PET data.Regulation of dopaminergic function: an [18F]-DOPA PET apomorphine challenge study in humans.Test-retest reproducibility of quantitative binding measures of [11C]Ro15-4513, a PET ligand for GABAA receptors containing alpha5 subunits.A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET method.Dopamine function in cigarette smokers: an [¹⁸F]-DOPA PET study.Voxelwise quantification of [(11)C](R)-rolipram PET data: a comparison between model-based and data-driven methods.Use of spectral analysis with iterative filter for voxelwise determination of regional rates of cerebral protein synthesis with L-[1-11C]leucine PETQuantification of [(11)C]PIB PET for imaging myelin in the human brain: a test-retest reproducibility study in high-resolution research tomography.Improved models for plasma radiometabolite correction and their impact on kinetic quantification in PET studiesFunctional reorganization in obstructive sleep apnoea and insomnia: A systematic review of the resting-state fMRI.Kinetic modelling of [(11)C]PBR28 for 18 kDa translocator protein PET data: A validation study of vascular modelling in the brain using XBD173 and tissue analysis.Amyloid pathology and axonal injury after brain trauma.Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.Measuring specific receptor binding of a PET radioligand in human brain without pharmacological blockade: The genomic plot.The PET Radioligand 18F-FIMX Images and Quantifies Metabotropic Glutamate Receptor 1 in Proportion to the Regional Density of Its Gene Transcript in Human Brain.Dynamic imaging of individual remyelination profiles in multiple sclerosis.Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease.Assessing radiotracer kinetics in the Langendorff perfused heart.Plasma radiometabolite correction in dynamic PET studies: Insights on the available modeling approaches.Spectral Analysis of Dynamic PET Studies: A Review of 20 Years of Method Developments and Applications.Modelling arterial input functions in positron emission tomography dynamic studies.Multimodal Partial-Volume Correction: Application to 18F-Fluoride PET/CT Bone Metastases Studies.Protein synthesis is associated with high-speed dynamics and broad-band stability of functional hubs in the brain.Erratum to: Test-retest analysis of a non-invasive method of quantifying [(11)C]-PBR28 binding in Alzheimer's disease.The effect of perinatal brain injury on dopaminergic function and hippocampal volume in adult life.Impact of tissue kinetic heterogeneity on PET quantification: case study with the L-[1-11C]leucine PET method for cerebral protein synthesis rates.Multimodal partial volume correction: Application to [11C]PIB PET/MRI myelin imaging in multiple sclerosis.Comparison of two PET radioligands, [11C]FPEB and [11C]SP203, for quantification of metabotropic glutamate receptor 5 in human brain.Pseudoreference Regions for Glial Imaging with 11C-PBR28: Investigation in 2 Clinical Cohorts.Brain TSPO imaging and gray matter volume in schizophrenia patients and in people at ultra high risk of psychosis: An [(11)C]PBR28 study.Presynaptic Dopamine Capacity in Patients with Treatment-Resistant Schizophrenia Taking Clozapine: An [18F]DOPA PET Study.A non-linear mixed effect modelling approach for metabolite correction of the arterial input function in PET studies.A Test of the Transdiagnostic Dopamine Hypothesis of Psychosis Using Positron Emission Tomographic Imaging in Bipolar Affective Disorder and Schizophrenia.Quantification of Dynamic [18F]FDG Pet Studies in Acute Lung Injury.
P50
Q23992160-78EB2BCE-8537-45A0-B5D3-E80F15771259Q26778370-AFAE61E7-2EFD-4EA0-8F7D-1B957D082C09Q30785495-3EA1E341-4F3E-4766-9D48-7B72E63CC38DQ30794621-BF2A01AA-1579-4CDA-A965-44F6EAAB531BQ30837683-45C9089E-E826-4481-94DF-54110AF1B33EQ31046346-07826771-B48B-4D2E-B6C7-4ED949493D9FQ31163202-26A0C428-DE49-4984-A618-1AEFD21FEF28Q33707670-B2DB0329-A5BD-4FB5-B4C5-43414356ABE0Q33714533-ABCB80A6-5F41-4AEE-A643-2524DB0624DEQ34009095-A83E5FC3-570B-4014-9C8B-F71DB5B02948Q34068906-1DD96ECA-7E95-4B82-A1FF-526B7152A06CQ34628071-0DB316E5-CDCD-462C-B92B-0065C06CA65FQ36008253-E4B781A1-CF71-4B11-ABCF-192BA7086B48Q36254332-04A3106C-3D16-4BF2-84D7-72A911416DE5Q36267474-514C4A77-4C67-45AC-9BA5-853EE1544F97Q36323358-20B65BEC-1E9F-4B57-BC81-065526B43D1DQ36392550-1E530588-1332-43EC-AAD5-E62737F3D443Q36691997-7E58037B-40B1-4E5F-A19E-775F51490931Q36766806-F9B6DEA8-7E27-43AE-B69A-64625A8CD1A8Q37172834-720D1F59-1C0A-4A3C-B2F4-FB414DA1EBEFQ37172845-3E45BA28-1022-458F-987B-0E1F5E3547BDQ37221998-823338A2-762D-4F4E-971F-75DEFA8FDBCDQ37289910-B6433D4A-23BA-4316-9758-0C95E6FEF13BQ37317584-A871107B-120C-48E4-BE9D-991C493518F5Q38667698-A0064A7D-2944-45D3-B4A6-8AB68400CB4BQ39042001-CF194A39-4E98-4AF6-B395-CBBA127F6E65Q40138792-B56B92EA-E26B-481D-8FCB-966730A648C4Q40727971-C5D11EE1-FC97-4701-B6B5-804A8672E995Q41074208-A7AE8988-3A6F-4C23-8A57-C2BB35971E91Q42321512-AE604601-7E46-48EB-9BB9-766244D1EE67Q47105586-6109E7AE-AE3F-493F-A3D4-8910FB14441FQ47554795-32A07C72-B67F-467A-BDA3-7D1FDF6C3796Q47821841-0AC5EDD4-24C5-410A-AEDA-D254F3510C11Q47938269-B38813F3-2811-47E4-9F96-5051DAE82F92Q47938329-2982165C-DB50-47C8-8EFB-2BAC047BE5BBQ48118494-A2402F94-584B-4E08-B1DA-90A0B535BC79Q48219402-EDF31D41-BBD1-40F9-8544-8777C3AE3714Q49057312-CE4069E5-0909-41FF-B933-49FBACD4E107Q50096180-B46B2E26-4E74-4851-8063-474228E2AEABQ50894731-E817960E-98B1-41B3-A64E-9023985015AD
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Mattia Veronese
@ast
Mattia Veronese
@en
Mattia Veronese
@es
Mattia Veronese
@nl
Mattia Veronese
@sl
type
label
Mattia Veronese
@ast
Mattia Veronese
@en
Mattia Veronese
@es
Mattia Veronese
@nl
Mattia Veronese
@sl
prefLabel
Mattia Veronese
@ast
Mattia Veronese
@en
Mattia Veronese
@es
Mattia Veronese
@nl
Mattia Veronese
@sl
P1053
A-6012-2013
P106
P1153
36487315800
P21
P2456
P31
P3829
P496
0000-0003-3562-0683